Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Hanamura

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Hematology|May 9, 2022
Multiple myeloma with high-risk cytogenetics and its treatment approachIchiro Hanamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Molecular pathogenesis of myeloma for the therapeutic targets]Ichiro Hanamura
Cancers|January 15, 2021
Gain/Amplification of Chromosome Arm 1q21 in Multiple MyelomaIchiro Hanamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Advances in multiple myeloma molecular biology research]Ichiro Hanamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 8, 2018
[Multiple myeloma: update on pathophysiology and management]Ichiro Hanamura, Shinsuke Iida
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Classification and genetic abnormalities of multiple myeloma]Ichiro Hanamura, Shinsuke Iida
Cancer Medicine|June 14, 2026
Awareness and Utilization of the Revised Second International Staging System (R2-ISS) and 1q21 Gain/Amplification Testing: A Nationwide Web-Based Survey of Hematologists in JapanNami Tagami, Heigoroh Shirai, Ichiro Hanamura
Internal Medicine (Tokyo, Japan)|December 10, 2025
Successes and Challenges of Bispecific T-cell Engager Antibodies in the Treatment of Multiple MyelomaIchiro Hanamura, Sivasundaram Karnan, Akinobu Ota, et al.
International Journal of Molecular Sciences|July 12, 2025
Primary Plasma Cell Leukemia: Recent Advances in Molecular Understanding and Treatment ApproachesIchiro Hanamura, Sivasundaram Karnan, Akinobu Ota, et al.
Hematological Oncology|August 22, 2020
Combining T-cell-based immunotherapy with venetoclax elicits synergistic cytotoxicity to B-cell lines in vitroSatsuki Murakami, Susumu Suzuki, Ichiro Hanamura, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Hematology|May 9, 2022
Multiple myeloma with high-risk cytogenetics and its treatment approachIchiro Hanamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Molecular pathogenesis of myeloma for the therapeutic targets]Ichiro Hanamura
Cancers|January 15, 2021
Gain/Amplification of Chromosome Arm 1q21 in Multiple MyelomaIchiro Hanamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Advances in multiple myeloma molecular biology research]Ichiro Hanamura
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 8, 2018
[Multiple myeloma: update on pathophysiology and management]Ichiro Hanamura, Shinsuke Iida
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2015
[Classification and genetic abnormalities of multiple myeloma]Ichiro Hanamura, Shinsuke Iida
Cancer Medicine|June 14, 2026
Awareness and Utilization of the Revised Second International Staging System (R2-ISS) and 1q21 Gain/Amplification Testing: A Nationwide Web-Based Survey of Hematologists in JapanNami Tagami, Heigoroh Shirai, Ichiro Hanamura
Internal Medicine (Tokyo, Japan)|December 10, 2025
Successes and Challenges of Bispecific T-cell Engager Antibodies in the Treatment of Multiple MyelomaIchiro Hanamura, Sivasundaram Karnan, Akinobu Ota, et al.
International Journal of Molecular Sciences|July 12, 2025
Primary Plasma Cell Leukemia: Recent Advances in Molecular Understanding and Treatment ApproachesIchiro Hanamura, Sivasundaram Karnan, Akinobu Ota, et al.
Hematological Oncology|August 22, 2020
Combining T-cell-based immunotherapy with venetoclax elicits synergistic cytotoxicity to B-cell lines in vitroSatsuki Murakami, Susumu Suzuki, Ichiro Hanamura, et al.
Pageof 9